Invest
27 Years
4.4 Star
1 Crore +
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q3FY24 results:
- Gross revenue at Rs 609 crore for the Q3FY24, an increase of 7.1% on a YoY and a decrease of 7.1% on a QoQ basis.
- Reported operating EBITDA of Rs 150 crore for the Q3FY24, a decrease of 4.6% YoY and 16.5% QoQ basis.
- Reported EBITDA margin at 24.7% vs. 27.7% in Q3FY23 and 27.5% in Q2FY24.
- PAT at Rs 77 crore in Q3FY24 against Rs 82 crore and Rs 101 crore in Q3FY23 and Q2FY24 respectively.
- Conducted 3.92 lakh OPD consults in Q3FY24, up by 2.7% on YoY and decreased by 7.3% on QoQ basis.
- Bed occupancy in Q3FY24 at 72.2%, up by 3.9% on YoY and down by 4.2% QoQ basis.
- ARPOB decreased marginally to Rs 30,741 in Q3FY24, a 3.1% increase YoY and 1.3% decrease on QoQ basis.
- Cash and Cash Equivalents at Rs 105 crore in Q3FY24.Net Debt to Equity ratio at 0.33
Announcing Q3 results, Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: “ We have seen a dip in patient footfalls this quarter. Traditionally, this happens to be slack season on account of festivals. Besides, the cyclone in Andhra Pradesh and assembly elections in Telangana have shown some impact. But I am particularly pleased to see that all our units have continued to produce excellent clinical outcomes. We should be opening our Nashik unit in Q1FY25. I am optimistic that we are on track to achieve our targets for FY24.”
FAQ’s on Krishna Institute of Medical Sciences Ltd Shares
